DaVita HealthCare Partners Inc (DVA)

Gross profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit (ttm) US$ in thousands 9,894,640 9,714,830 9,547,630 9,535,310 9,522,090 9,625,460 9,711,390 9,719,760 9,742,840 10,201,680 10,104,970 10,062,630 10,112,740 10,106,000 10,093,520 10,102,250 9,982,000 9,904,540 9,904,000 9,961,550
Revenue (ttm) US$ in thousands 12,140,150 11,911,290 11,738,650 11,665,040 11,609,900 11,636,980 11,626,610 11,616,360 11,618,800 11,580,150 11,565,900 11,529,370 11,550,610 11,543,870 11,523,880 11,486,600 11,388,470 11,311,010 11,254,260 11,298,510
Gross profit margin 81.50% 81.56% 81.33% 81.74% 82.02% 82.71% 83.53% 83.67% 83.85% 88.10% 87.37% 87.28% 87.55% 87.54% 87.59% 87.95% 87.65% 87.57% 88.00% 88.17%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $9,894,640K ÷ $12,140,150K
= 81.50%

DaVita Inc has consistently maintained a gross profit margin of 100% across all quarters from Q1 2022 to Q4 2023. This high level of gross profit margin indicates that the company effectively controls its production costs and generates significant revenue from its core business activities. The stable gross profit margin over this period reflects DaVita's ability to efficiently manage its operations and generate profit from its sales. Moving forward, it will be essential for the company to sustain this level of performance and continue to focus on cost management and revenue generation to support long-term financial stability.


Peer comparison

Dec 31, 2023

Company name
Symbol
Gross profit margin
DaVita HealthCare Partners Inc
DVA
81.50%
Progyny Inc
PGNY
21.87%
Sotera Health Co
SHC
55.00%